Awareness of Nucleic Acid-Based Therapies

October 25, 2019

Dr. Melissa Moore, global messenger RNA (mRNA) expert and chief scientific officer of Moderna’s mRNA research platform, joins Dr. Diane Hayes, InCrowd co-founder and board member, for Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines, a webinar examining the emerging therapy area, medications in the field, and analysis of recent InCrowd prescriber research.

Key learnings:


  • A high-level understanding of the emerging class of therapeutics based on molecular biology approaches to altering gene expression by targeting nucleic acids (DNA and RNA)
  • Prescriber awareness of nucleic acid-based medicines
  • Insight across a variety of specialists from academic medical centers, as well as other practice settings
  • Prescriber perceptions of the potential impact of nucleic acid-based medicines
Who should watch:


  • Anyone interested in nucleic acid-based medicines
  • Healthcare and life science marketers, market insights, research, new business, and commercialization professionals
  • Healthcare and hospital administrators
  • Physicians and biologists interested or involved in nucleic acid-based medicines
  • Payors
  • Pharmacists
  • Those interested in therapeutic innovation

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.